InsidersTradesSigma
Total declarations
Company
▲ Purchases (12 ops.)
▼ Sales (0 ops.)
Insider track record
OtherDisclosed buys
12
Disclosed sells
0
T+90 hit rate
25%
T+90 mean return
+10.8%
Across 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the full record of transactions filed by Shemesh Shay. Insider active across 1 company, notably Nuvectis Pharma, Inc.. Cumulatively, 17 reports have been logged. Split: 12 buys · 0 sell. Total volume traded: €53k. History available since 4 February 2022. The latest transaction was filed on 6 January 2026 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Shemesh Shay
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations17 total
150,000 shares0Common StockSEC:0001104659-26-002501:0
150,000 shares0Common StockSEC:0001104659-25-000913:0
1,113 shares@ US$6.3211.1% of flowCommon StockSEC:0001104659-24-060261:0
Canonical exit: 8 Aug 2024 (T+90)
130,000 shares0Common StockSEC:0001104659-24-001820:0
420 shares@ US$11.998.0% of flowCommon StockSEC:0001104659-23-035392:0
Canonical exit: 19 Jun 2023 (T+90)
670 shares@ US$10.7111.3% of flowCommon StockSEC:0001104659-23-033594:0
Canonical exit: 13 Jun 2023 (T+90)
115,000 shares0Common StockSEC:0001104659-23-003863:0
500 shares@ US$7.656.1% of flowCommon StockSEC:0001104659-22-129348:0
Canonical exit: 21 Mar 2023 (T+90)
150 shares@ US$7.101.7% of flowCommon StockSEC:0001104659-22-120080:0
Canonical exit: 14 Feb 2023 (T+90)
220 shares@ US$7.873.0% of flowCommon StockSEC:0001104659-22-103166:0
Canonical exit: 22 Dec 2022 (T+90)
404 shares@ US$8.315.7% of flowCommon StockSEC:0001104659-22-097692:0
Canonical exit: 1 Dec 2022 (T+90)
1,476 shares@ US$8.0720.1% of flowCommon StockSEC:0001104659-22-097216:0
Canonical exit: 29 Nov 2022 (T+90)
300 shares@ US$16.540.0016% mcap24.1% of flowCommon StockSEC:0001104659-22-063644:0
Canonical exit: 18 Aug 2022 (T+90)
100 shares@ US$19.280.0006% mcap9.5% of flowCommon StockSEC:0001104659-22-062271:0
Canonical exit: 14 Aug 2022 (T+90)
36 shares@ US$14.580.0002% mcap2.6% of flowCommon StockSEC:0001104659-22-059890:0
Canonical exit: 10 Aug 2022 (T+90)
60,000 shares0Common StockSEC:0001104659-22-042814:0
2,100 shares@ US$3.380.0021% mcap31.9% of flowCommon Stock, par value $0.00001SEC:0001104659-22-014375:0
Canonical exit: 5 May 2022 (T+90)
17 of 17 declarations
About Shemesh Shay
Shemesh Shay is a director at Nuvectis Pharma, Inc.
